KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Current Leases (2019 - 2025)

Historic Current Leases for Fulgent Genetics (FLGT) over the last 7 years, with Q3 2025 value amounting to $1.5 million.

  • Fulgent Genetics' Current Leases rose 40.51% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 40.51%. This contributed to the annual value of $1.4 million for FY2024, which is 6353.3% down from last year.
  • Latest data reveals that Fulgent Genetics reported Current Leases of $1.5 million as of Q3 2025, which was up 40.51% from $1.2 million recorded in Q2 2025.
  • Fulgent Genetics' Current Leases' 5-year high stood at $6.1 million during Q4 2022, with a 5-year trough of $1.0 million in Q2 2021.
  • Moreover, its 5-year median value for Current Leases was $1.5 million (2025), whereas its average is $2.3 million.
  • In the last 5 years, Fulgent Genetics' Current Leases skyrocketed by 25742.19% in 2021 and then crashed by 6353.3% in 2024.
  • Over the past 5 years, Fulgent Genetics' Current Leases (Quarter) stood at $1.8 million in 2021, then surged by 235.08% to $6.1 million in 2022, then crashed by 35.47% to $4.0 million in 2023, then crashed by 63.53% to $1.4 million in 2024, then grew by 3.05% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $1.2 million for Q2 2025, and $1.3 million during Q1 2025.